FI763257A - - Google Patents

Info

Publication number
FI763257A
FI763257A FI763257A FI763257A FI763257A FI 763257 A FI763257 A FI 763257A FI 763257 A FI763257 A FI 763257A FI 763257 A FI763257 A FI 763257A FI 763257 A FI763257 A FI 763257A
Authority
FI
Finland
Application number
FI763257A
Other languages
Finnish (fi)
Other versions
FI62462C (fi
FI62462B (fi
Inventor
Conny Boerje Bogentoft
Curt Henry Appelgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI763257A publication Critical patent/FI763257A/fi
Application granted granted Critical
Publication of FI62462B publication Critical patent/FI62462B/fi
Publication of FI62462C publication Critical patent/FI62462C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
FI763257A 1975-11-17 1976-11-12 Foerfarande foer framstaellning av preparat som kontrollerat avger en aktiv komponent FI62462C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7512883A SE418247B (sv) 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
SE7512883 1975-11-17

Publications (3)

Publication Number Publication Date
FI763257A true FI763257A (da) 1977-05-18
FI62462B FI62462B (fi) 1982-09-30
FI62462C FI62462C (fi) 1983-01-10

Family

ID=20326096

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763257A FI62462C (fi) 1975-11-17 1976-11-12 Foerfarande foer framstaellning av preparat som kontrollerat avger en aktiv komponent

Country Status (24)

Country Link
US (2) US4289795A (da)
JP (1) JPS5919526B2 (da)
AT (1) AT354636B (da)
AU (1) AU508266B2 (da)
BE (1) BE848406A (da)
CA (1) CA1075031A (da)
CS (1) CS207374B2 (da)
DD (1) DD128170A5 (da)
DE (1) DE2651176A1 (da)
DK (1) DK146213C (da)
FI (1) FI62462C (da)
FR (1) FR2331375A1 (da)
GB (1) GB1560841A (da)
HK (1) HK14683A (da)
HU (1) HU173461B (da)
IE (1) IE44353B1 (da)
LU (1) LU76215A1 (da)
MY (1) MY8400019A (da)
NL (1) NL187259C (da)
NO (1) NO144763C (da)
NZ (1) NZ182621A (da)
SE (1) SE418247B (da)
SU (1) SU1326180A3 (da)
ZA (1) ZA766669B (da)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE426548B (sv) 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
EP0111560A4 (en) * 1982-06-14 1987-02-03 Key Pharma ASPIRINE WITH CONTINUOUS LEVEL.
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
EP0113373B1 (en) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
CA1223172A (en) * 1982-09-23 1987-06-23 Sidney Melamed Encapsulated solid microbiocidal article
US5283060A (en) * 1982-09-29 1994-02-01 Shieh Tsuong R Bacillus-containing pesticide granules
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
US5100592A (en) * 1986-03-12 1992-03-31 Washington University Technology Associated, Inc. Method and apparatus for granulation and granulated product
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
KR910002669B1 (ko) * 1986-12-25 1991-05-03 데이산세이야꾸 가부시끼가이샤 서방성 과립 및 그를 함유하는 지속성 복합과립
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4971796A (en) * 1988-10-05 1990-11-20 Sjogren Robert D Slow release pest control granule composition
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US5055307A (en) * 1988-12-29 1991-10-08 Asahi Kagaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE3918801A1 (de) * 1989-06-06 1991-05-08 Schmidt Walter Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung
JP2813809B2 (ja) * 1989-06-19 1998-10-22 武田薬品工業株式会社 有核顆粒製剤およびその製造法
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
AU683044B2 (en) * 1992-12-23 1997-10-30 Saitec S.R.L. Process for preparing controlled release pharmaceutical forms and the forms thus obtained
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
EP1949890A3 (en) 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
NZ515911A (en) * 1999-06-04 2004-02-27 Alza Corp Implantable gel compositions and method of manufacture
EP1276470B1 (en) 2000-04-20 2007-05-02 Novartis AG Taste masking coating composition
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
ES2663873T3 (es) 2001-10-29 2018-04-17 Massachusetts Institute Of Technology Forma farmacéutica con perfil de liberación de orden cero fabricada por impresión tridimensional
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0228421D0 (en) * 2002-12-05 2003-01-08 Exosect Ltd Lipid carriers
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
KR20060015587A (ko) 2003-05-08 2006-02-17 넥타 쎄라퓨틱스 유케이 리미티드 미립물
GB0310636D0 (en) * 2003-05-08 2003-06-11 Nektar Therapeutics Uk Ltd Particulate materials
JP2007530665A (ja) * 2004-03-31 2007-11-01 エイド パリー （インディア） リミテッド ニーム種子抽出物の改良された顆粒製剤化およびその方法
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
DE602006020642D1 (de) * 2005-01-06 2011-04-21 Cima Labs Inc Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
BE623704A (da) * 1961-10-20
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
DE1617351A1 (da) * 1967-06-28 1972-01-05
DK123806B (da) * 1970-06-08 1972-08-07 Pharmacia As Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof.
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation

Also Published As

Publication number Publication date
JPS5919526B2 (ja) 1984-05-07
US4289795A (en) 1981-09-15
BE848406A (fr) 1977-05-17
IE44353B1 (en) 1981-11-04
NZ182621A (en) 1978-12-18
HK14683A (en) 1983-05-13
ATA850576A (de) 1979-06-15
FI62462C (fi) 1983-01-10
GB1560841A (en) 1980-02-13
DK513476A (da) 1977-05-18
MY8400019A (en) 1984-12-31
NO144763B (no) 1981-07-27
LU76215A1 (da) 1977-06-06
ZA766669B (en) 1977-10-26
NL187259C (nl) 1991-08-01
DK146213C (da) 1984-01-16
DK146213B (da) 1983-08-01
NO144763C (no) 1981-11-04
FI62462B (fi) 1982-09-30
NL187259B (nl) 1991-03-01
AU1961776A (en) 1978-05-25
AU508266B2 (en) 1980-03-13
AT354636B (de) 1979-01-25
DD128170A5 (de) 1977-11-02
FR2331375B1 (da) 1981-12-31
IE44353L (en) 1977-05-17
SE7512883L (sv) 1977-05-18
DE2651176C2 (da) 1987-06-11
CA1075031A (en) 1980-04-08
NO763807L (da) 1977-05-20
HU173461B (hu) 1979-05-28
CS207374B2 (en) 1981-07-31
US4341759A (en) 1982-07-27
SU1326180A3 (ru) 1987-07-23
NL7612728A (nl) 1977-05-20
SE418247B (sv) 1981-05-18
JPS5283921A (en) 1977-07-13
FR2331375A1 (fr) 1977-06-10
DE2651176A1 (de) 1977-05-18

Similar Documents

Publication Publication Date Title
NO763807L (da)
ATA280176A (da)
JPS567385B2 (da)
JPS51141088U (da)
JPS566452Y2 (da)
JPS5233676U (da)
JPS51125614U (da)
JPS5352973Y2 (da)
JPS5720697B2 (da)
JPS5289880U (da)
JPS5228365U (da)
JPS5193344U (da)
JPS51148702U (da)
JPS51140488U (da)
JPS51125730U (da)
JPS5199183A (da)
CH599376A5 (da)
CH597602A5 (da)
CH600370A5 (da)
CH600149A5 (da)
CH599768B5 (da)
CH599667A5 (da)
CH599655A5 (da)
CH599463A5 (da)
CH596178A5 (da)

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: AB HAESSLE